Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Exponent Q2 2024 GAAP EPS $0.57 Beats $0.50 Estimate, Sales $140.536M Beat $130.827M Estimate

Author: Benzinga Newsdesk | July 25, 2024 03:22pm
Exponent (NASDAQ:EXPO) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.50 by 14 percent. The company reported quarterly sales of $140.536 million which beat the analyst consensus estimate of $130.827 million by 7.42 percent. This is a 0.22 percent increase over sales of $140.221 million the same period last year.

Posted In: EXPO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist